Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
T Cell Types and Functions01:24

T Cell Types and Functions

830
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
830
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cis.

Science signaling·2025
Same author

Inhibitory pattern recognition receptors: lessons from LAIR1.

Nature reviews. Immunology·2025
Same author

A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets.

eLife·2024
Same author

In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients.

Cancer immunology, immunotherapy : CII·2024
Same author

Mechanosensing regulates tissue repair program in macrophages.

Science advances·2024
Same author

Sensing context: Inhibitory receptors on non-hematopoietic cells.

European journal of immunology·2023
Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026
Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026
Same journal

Complement in Traumatic Brain Injury: Linking Acute Injury to Chronic Neurodegeneration.

European journal of immunology·2026
Same journal

Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles.

European journal of immunology·2026
Same journal

Methodological Insights Into T-Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation.

European journal of immunology·2026
See all related articles

Related Experiment Video

Updated: May 26, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.0K

VSTM1/SIRL-1: An Inhibitory Pattern Recognition Receptor Regulating Myeloid Cells.

Maaike Koops1,2, Linde Meyaard1,2

  • 1Center of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

European Journal of Immunology
|February 24, 2025
PubMed
Summary
This summary is machine-generated.

V-set and transmembrane domain containing 1 (VSTM1), or signal inhibitory receptor on leukocytes-1 (SIRL-1), is an inhibitory receptor on myeloid cells. It regulates immune responses and shows potential as a therapeutic target in diseases like cancer.

Keywords:
SIRL‐1VSTM1inhibitory receptorspattern recognition receptors

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.4K
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

260

Related Experiment Videos

Last Updated: May 26, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.0K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.4K
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

260

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Innate immune cells utilize inhibitory receptors to balance immune activation and prevent self-damage.
  • V-set and transmembrane domain containing 1 (VSTM1), also known as signal inhibitory receptor on leukocytes-1 (SIRL-1), is an inhibitory receptor found on myeloid cells.

Purpose of the Study:

  • To review the characteristics and functions of VSTM1 in both healthy and diseased states.
  • To highlight VSTM1's role as an inhibitory pattern recognition receptor and its therapeutic potential.

Main Methods:

  • Literature review of studies on VSTM1/SIRL-1 function.
  • Analysis of VSTM1's role in modulating myeloid cell activity, including reactive oxygen species and neutrophil extracellular trap formation.
  • Examination of VSTM1's involvement in pathological conditions.

Main Results:

  • VSTM1 acts as an inhibitory receptor, modulating myeloid cell functions.
  • It recognizes molecular patterns from both self and microbial sources, classifying it as an inhibitory pattern recognition receptor.
  • VSTM1 is implicated in autoimmune disorders and cancer.

Conclusions:

  • VSTM1 plays a crucial role in immune regulation by myeloid cells.
  • Its function in recognizing diverse molecular patterns and its involvement in disease make it a promising therapeutic target.
  • Further research into VSTM1 could lead to novel treatments for immune-related pathologies.